PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients
Proceedings article published in 2017 by
Eduard Gorina,
Luca Richeldi,
Ganesh Raghu,
Evans Fernandez Perez,
Ulrich Costabel,
Carlo Albera,
David Lederer,
Kevin Flaherty,
Neil Ettinger,
Peter Bercz,
Bhanu Singh,
Rafael Perez,
Jonathan Goldin,
Elias Kouchakji,
Seth Porter
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
